What’s in the needle? A look at Ebola vaccine candidate VSV-EBOV

On: October 14, 2014

[B]eginning about fifteen years ago, several teams of researchers in various nations began in earnest to pursue a viable vaccine against Ebola and Marburg filoviruses. In about 2013, two candidates reached monkey experiments (what are commonly called ‘non-human primate’ trials) and reported rousing success. Today, we’ll discuss one of thoseContinue Reading

Hey, Kids! Squalene’s Back!

By: Sharon

On: October 7, 2014

In: Avian Flu, Biological Threats, Connecting Dots, Emerging Diseases, Pestilence & Disease

[L]ongtime listeners to our internet podcast, PID Radio, may remember that back in 2009 or so, Derek and I were talking about the government’s proposal that Swine Flu vaccine manufacturers be allowed to add an adjuvant to their vaccine cocktails to keep costs to a minimum and ‘stretch’ the amountContinue Reading

VLP Tech Means Big Money: Takeda to Acquire LigoCyte Pharmaceuticals, Inc.

By: Sharon

On: October 7, 2012

In: Genetics, Science

This little press release caught my eye this afternoon—as I sit home slogging through a second bout of gastroenteritis in a few months. Both Derek and a close friend mentioned that a neighboring town closed their schools a few weeks ago due to an outbreak of Norovirus, which may orContinue Reading

Vaccines (Page 2)